Filing Details
- Accession Number:
- 0001104659-23-072222
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-16 16:05:38
- Reporting Period:
- 2023-06-14
- Accepted Time:
- 2023-06-16 16:05:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
727510 | Enzon Pharmaceuticals Inc. | ENZN | Biological Products, (No Disgnostic Substances) (2836) | 222372868 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1074613 | C Randolph Read | C/O Enzon Pharmaceuticals, Inc. 20 Commerce Drive (Suite 135) Cranford NJ 07016 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-14 | 15,000 | $0.13 | 115,450 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-06-16 | 84,550 | $0.14 | 200,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |